The Rapid Blog & News

Rapid Micro Biosystems Awarded Contract by Biomedical Advanced Research and Development Authority (BARDA) to Develop Rapid Sterility Testing Platform for Vaccines

Written by Admin User | Sep 22, 2010 6:27:00 PM

Bedford, MA - (September 22, 2010) – Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection, today announced that it has signed a contract with the Biomedical Advanced Research and Development Authority (BARDA) for the development of rapid sterility testing for vaccines as part of the Innovative Platform Technologies program of BARDA’s Strategic Science and Technology Division.  

Under the terms of the agreement, Rapid Micro Biosystems will receive $2.2 million in the first contract year and up to an additional $4.5 million in two option years, for a total contract value of $6.7 million.

 “We are pleased to be awarded this contract by BARDA”, said Steve Delity, Chief Executive Officer of Rapid Micro Biosystems. “Rapid Micro is the leader in automated rapid detection, and we look forward to working closely with BARDA to develop a solution to help with pandemic response.”

Reducing the time-to-release of vaccines or other biopharmaceutical countermeasures will facilitate prevention and control of epidemic diseases like influenza, other emerging infections and agents of bioterrorism.  Faster microbiological quality control (QC) testing will reduce the release cycle of vaccines by as much as two to four weeks. This time decrease will save countless lives by accelerating the release of safe product to the public in the event of a pandemic or bioterrorism attack.

About Rapid Micro Biosystems

Rapid Micro Biosystems, headquartered in Bedford, Massachusetts, provides innovative products for faster, automated detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products. The Company’s Growth Direct™ System detects contamination earlier, delivering compelling economic benefits to manufacturers while improving their quality process. The Growth Direct™ System is the first and only automated system that accelerates testing, fits with current regulatory practices, and addresses all key applications. For more information, visit

Rapid Micro Biosystems
Mark Severns, 781-271-1444
Sr. Marketing Manager